Case_id: case_165
Case_description: 
A type of fatal adrenal cancer has an average survival rate of 3 years after the onset of clinically significant symptoms. It is determined that patients have a 4-year asymptomatic period prior to developing clinical symptoms from this adrenal cancer. A new screening test is developed, and the cancer can now be detected 2 years prior to developing clinical symptoms. A new observational case-control study of screened and unscreened patients measures the median 5-year survival of patients who decline medical and surgical treatment. The screened population has statistically better outcomes. Which step should be undertaken to prevent bias in these conclusions?
Options: 
1. Using survival rates in the analysis
2. Using mortality rates in the analysis
3. Analyzing the results by age of diagnosis
4. Increasing the number of screened individuals
5. Decreasing the number of screened individuals
Correct Answer: Using mortality rates in the analysis

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 2 (Using mortality rates in the analysis)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**
- **Patient Information and Chief Complaint:** The case involves patients diagnosed with a fatal adrenal cancer characterized by a 4-year asymptomatic period followed by clinically significant symptoms. The average survival rate post-symptom onset is 3 years.
- **Key Clinical Manifestations:** 
  - **Asymptomatic Period:** Patients remain symptom-free for approximately 4 years before symptom onset.
  - **Post-Symptom Onset:** Once clinical symptoms manifest, the prognosis is poor, with an average survival of 3 years.
  - **Screening Detection:** A new screening test is capable of identifying the cancer 2 years prior to the development of clinical symptoms.
  - **Study Outcome:** An observational case-control study indicates that screened patients who decline treatment have a statistically better median 5-year survival compared to unscreened patients.

**2. Analysis of Clinical Features**
- **Timeline and Detection:** The natural history of the adrenal cancer includes a total of 7 years from initial asymptomatic phase to average demise post-symptom onset. The screening test advances detection by 2 years before symptom development.
- **Survival Measurement:** The study measures median survival from the time of diagnosis, not accounting for the extended pre-symptomatic detection window introduced by screening.
- **Potential Bias:** Detecting the cancer earlier does not necessarily prolong life but may artificially inflate survival statistics due to earlier timepoints of diagnosis without affecting the actual time of death.
  
**3. Differential Diagnosis Analysis**
- **Option 1: Using survival rates in the analysis**
  - **Assessment:** Using survival rates from the time of diagnosis can introduce lead-time bias, as earlier detection artificially extends the observed survival time without affecting the actual course of the disease.
- **Option 2: Using mortality rates in the analysis**
  - **Assessment:** Mortality rates are less susceptible to lead-time bias as they measure the actual number of deaths over a period, irrespective of when the disease was detected.
- **Option 3: Analyzing the results by age of diagnosis**
  - **Assessment:** While age can be a confounding factor, it does not directly address the bias introduced by earlier detection.
- **Option 4: Increasing the number of screened individuals**
  - **Assessment:** Increasing sample size may improve statistical power but does not inherently resolve bias issues related to study design.
- **Option 5: Decreasing the number of screened individuals**
  - **Assessment:** Reducing the number of screened individuals would not address the fundamental bias introduced by earlier detection capabilities.

**4. Final Selection**
**My final selection is: Option 2 (Using mortality rates in the analysis)(使用死亡率进行分析)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 2 (Using mortality rates in the analysis)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- The case involves a fatal adrenal cancer with an average survival of 3 years from symptom onset. Patients have a 4-year asymptomatic phase before clinical symptoms develop. A new screening test detects the cancer 2 years earlier than symptom onset. A case-control study comparing screened (earlier detection) and unscreened patients shows better 5-year survival in the screened group.  
- Key issue: The observed survival benefit may be due to **lead-time bias** (earlier diagnosis extending the measured survival time without improving actual survival duration).  

**2. Analysis of Clinical Features**  
- **Timeline**:  
  - Asymptomatic period: 4 years.  
  - Screening detects cancer 2 years before symptom onset.  
  - Survival from symptom onset: 3 years.  
- **Survival Calculation**:  
  - Screened patients are diagnosed 2 years earlier, so their survival time is measured from an earlier point. For example:  
    - Unscreened: Diagnosed at symptom onset → Survival = 3 years (median).  
    - Screened: Diagnosed 2 years earlier → Survival = 3 + 2 = 5 years (median).  
  - This creates an **artificial survival "improvement"** due to earlier diagnosis, not better outcomes.  

**3. Differential Diagnosis Analysis**  
- **Option 1: Using survival rates in the analysis**  
  - **Weakness**: Survival rates are prone to **lead-time bias** in this context. The screened group’s longer survival time is merely due to earlier diagnosis, not actual prolongation of life.  
- **Option 2: Using mortality rates in the analysis**  
  - **Strength**: Mortality rates (e.g., death within a fixed time frame) are not affected by the timing of diagnosis. Comparing mortality rates would eliminate the bias introduced by earlier detection.  
  - Example: Compare death rates at 5 years from the start of the study (regardless of diagnosis timing). If both groups have similar mortality rates, the screening effect is spurious.  
- **Option 3: Analyzing results by age of diagnosis**  
  - **Irrelevant**: The problem is timing of diagnosis relative to symptom onset, not age.  
- **Options 4 and 5: Adjusting the number of screened individuals**  
  - **Irrelevant**: Increasing or decreasing sample size does not address methodological bias.  

**4. Final Selection**  
**My final selection is: Option 2 (Using mortality rates in the analysis)(在分析中使用死亡率)**  

**Key Evidence**:  
- Lead-time bias inflates survival rates when comparing groups with differing diagnosis times.  
- Mortality rates, measured from a fixed starting point (e.g., study enrollment), eliminate this bias by focusing on the proportion of patients who die within a defined timeframe, independent of when the cancer was detected.  
- Survival rates are misleading here because they conflate earlier diagnosis with improved outcomes, whereas mortality rates objectively assess whether the screening truly reduces deaths.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 2 (Using mortality rates in the analysis)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Medical Context**: A fatal adrenal cancer with a 3-year average survival after symptom onset. Patients have a 4-year asymptomatic period before symptoms develop. A new screening test detects the cancer 2 years earlier (2 years pre-symptoms).  
- **Study Findings**: A case-control study shows screened patients (detected earlier) have statistically better 5-year survival outcomes compared to unscreened patients, despite no treatment.  

**2. Analysis of Clinical Features**  
- **Critical Bias**: The study’s conclusion likely suffers from **lead-time bias**. Screening advances the diagnosis date without altering disease progression or mortality. Survival time is measured from diagnosis, so earlier detection artificially inflates survival duration, even if death occurs at the same biological time.  
- **Key Evidence**:  
  - Asymptomatic phase: 4 years.  
  - Screening advances diagnosis by 2 years but does not delay death.  
  - Survival metrics (time from diagnosis) are inherently skewed by earlier detection.  

**3. Differential Diagnosis Analysis**  
1. **Option 1 (Survival rates)**: Survival rates perpetuate lead-time bias by measuring time from diagnosis. This does not address the core issue.  
2. **Option 2 (Mortality rates)**: Mortality rates (deaths per population/time) eliminate lead-time bias by focusing on actual death timing, independent of diagnosis date. This directly corrects the bias.  
3. **Option 3 (Age analysis)**: Age stratification is unrelated to lead-time bias and does not resolve the study’s flawed survival metric.  
4. **Options 4/5 (Sample size adjustments)**: Increasing/decreasing screened individuals affects statistical power but does not address the methodological bias in survival measurement.  

**4. Final Selection**  
**My final selection is: Option 2 (Using mortality rates in the analysis)(在分析中使用死亡率)**  
- **Key Evidence**: Mortality rates measure outcomes based on death timing, avoiding artificial inflation of survival time due to earlier diagnosis. This adjustment eliminates lead-time bias, ensuring conclusions reflect true clinical benefit (or lack thereof).
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 2 (Using mortality rates in the analysis)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option2

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option2 - Using mortality rates in the analysis
Correct Answer: - Using mortality rates in the analysis

Is the final diagnosis correct? ✓ Correct

